Phase 3 Rheumatoid Arthritis (RA) Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
mAbxience Research S.L.458 enrolled60 locationsNCT06596772
Completed
Phase 3
Multi-National Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab versus Tocilizumab plus Non-biologic disease modifying antirheumatic drugs in Patients with Active Rheumatoid Arthritis
Active moderate to severe Rheumatoid Arthritis (RA)
Roche Products Pty Ltd70 enrolled21 locationsACTRN12608000397314
Recruiting
Phase 3
A Phase IIIB Multi-Center, Randomized, Double-Blind Study to Evaluate Remission and Joint Damage Progression in Methotrexate Naive Early Erosive RA Subjects Treated With Abatacept Plus Methotrexate Compared With Methotrexate
Rheumatoid Arthritis (RA)
Bristol-Myers Squibb Australia500 enrolled1 locationACTRN12605000784617